Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical Trial theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Eatontown, New Jersey (Newsfile Corp. - January 6, 2023) - American CryoStem Corporation (OTC Pink: CRYO), a clinical-stage therapeutics company with a proprietary end-to-end core biotechnology platform
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.
EQS-News: Defence Therapeutics Inc. / Key word(s): Study Defence Therapeutics Inc.: DEFENCE’S SUCCESSFULL STUDY ON THE ACCUVAC-PT007 VACCINE TARGETING CERVICAL CANCER 23.11.2022 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. .
Vancouver, British Columbia (Newsfile Corp. - November 23, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company